Abstract

Macrophage migration inhibitory factor (MIF) is a cytokine that has broad effects on immune system and inflammatory response. A growing body of evidence implicates the role of MIF in tumor growth and metastasis. Lysophosphatidic acid (LPA), a bioactive lipid mediator, regulates colon cancer cell proliferation, invasion, and survival through LPA2 receptor. Loss of LPA2 results in decreased expression of MIF in a rodent model of colon cancer, but the mechanism of MIF regulation by LPA is yet to be determined. In this study, we show that LPA transcriptionally regulates MIF expression in colon cancer cells. MIF knockdown decreased LPA-mediated proliferation of HCT116 human adenocarcinoma cells without altering the basal proliferation rates. Conversely, extracellular recombinant MIF stimulated cell proliferation, suggesting that the effect of MIF may in part be mediated through activation of surface receptor. We have shown recently that LPA increases hypoxia-inducible factor 1α (HIF1α) expression. We found that MIF regulation by LPA was ablated by knockdown of HIF1α, indicating that MIF is a transcriptional target of HIF1α. Conversely, knockdown of MIF ablated an increase in HIF1α expression in LPA-treated cells, suggesting a reciprocal relationship between HIF1α and MIF. LPA stimulated co-immunoprecipitation of HIF1α and MIF, indicating that their association is necessary for stabilization of HIF1α. It has been shown previously that CSN9 signalosome subunit 5 (CSN5) interacts with HIF1α to stabilize HIF1α under aerobic conditions. We found that LPA did not alter expression of CSN5, but stimulated its interaction with HIF1α and MIF. Depletion of CSN5 mitigated the association between HIF1α and MIF, indicating that CSN5 acts as a physical link. We suggest that HIF1α, MIF, and CSN5 form a ternary complex whose formation is necessary to prevent degradation of HIF1α under aerobic conditions.

Highlights

  • Macrophage migration inhibitory factor (MIF) was originally identified as a product of activated T cells, but it is recognized as a chemokine that plays a central role in innate and adaptive immunity [1]

  • The induction of MIF in HCT116 cells was LPA2 dependent since knockdown of LPA2 completely blocked the increase in MIF expression, consistent with an earlier finding that MIF expression is decreased in LPA2-null mice [25]

  • Previous studies showed that Lysophosphatidic acid (LPA) induced MIF in the mouse colon 26 cell line and loss of LPA2 decreased MIF expression in mouse intestine [19, 25], but how LPA regulates MIF has not been determined

Read more

Summary

Introduction

Macrophage migration inhibitory factor (MIF) was originally identified as a product of activated T cells, but it is recognized as a chemokine that plays a central role in innate and adaptive immunity [1]. Through its pro-inflammatory effects, MIF has been implicated in the pathogenesis of several acute and chronic inflammatory conditions, including rheumatoid. Macrophage Migration Inhibitory Factor and LPA arthritis, atherosclerosis, and septic shock [2]. MIF is expressed by a variety of cells including endothelial cells, mesenchymal cells, eosinophils, and epithelial cells. MIF is expressed primarily by epithelial cells, by a poorly characterized lamina propria cell population [3]. Inhibition or loss of MIF protects mice from chemically induced colitis, while transgenic MIF expression exacerbates colitic conditions [3, 6, 7]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call